Zymeworks Inc. (ZYME)

USD 12.74

(-4.71%)

Eps Summary of Zymeworks Inc.

Zymeworks Inc.'s latest annual eps in 2023 was -1.72 USD , down -190.05% from previous year.
Zymeworks Inc.'s latest quarterly eps in 2024 Q2 was -0.49 USD , down -16.67% from previous quarter.
Zymeworks Inc. reported an annual eps of 1.91 USD in 2022, up 147.04% from previous year.
Zymeworks Inc. reported an annual eps of -4.06 CAD in 2021, down -13.41% from previous year.
Zymeworks Inc. reported a quarterly eps of -0.42 USD for 2024 Q1, down -110.0% from previous quarter.
Zymeworks Inc. reported a quarterly eps of -392.10 USD for 2024 Q3, up 20.41% from previous quarter.

Annual Eps Chart of Zymeworks Inc. (2023 - 2014)

Historical Annual Eps of Zymeworks Inc. (2023 - 2014)

Year	Eps	Eps Growth
2023	-1.72 USD	-190.05%
2022	1.91 USD	147.04%
2021	-4.06 CAD	-13.41%
2020	-3.58 USD	6.53%
2019	-3.83 USD	-203.97%
2018	-1.26 USD	-157.14%
2017	-0.49 USD	71.51%
2016	-1.72 USD	-77.32%
2015	-0.97 USD	-49.23%
2014	-0.65 USD	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.49 USD	-16.67%
2024 Q1	-0.42 USD	-110.0%
2024 Q3	-392.10 USD	20.41%
2023 Q3	-0.41 USD	46.05%
2023 Q1	-0.36 USD	-107.74%
2023 Q2	-0.76 USD	-111.11%
2023 FY	- USD	-190.05%
2023 Q4	-0.20 USD	51.22%
2022 Q2	-0.97 USD	17.8%
2022 FY	- USD	147.04%
2022 Q4	4.65 USD	745.83%
2022 Q3	-0.72 USD	25.77%
2022 Q1	-1.18 USD	-55.26%
2021 Q4	-0.76 CAD	35.04%
2021 Q2	-1.31 USD	-50.57%
2021 FY	- CAD	-13.41%
2021 Q1	-0.87 USD	-17.57%
2021 Q3	-1.17 USD	10.69%
2020 Q2	-0.77 USD	-20.31%
2020 Q1	-0.64 USD	61.45%
2020 Q4	-0.74 USD	48.25%
2020 FY	- USD	6.53%
2020 Q3	-1.43 USD	-85.71%
2019 Q1	-0.43 USD	-248.28%
2019 FY	- USD	-203.97%
2019 Q4	-1.66 USD	-137.14%
2019 Q3	-0.70 USD	21.35%
2019 Q2	-0.89 USD	-106.98%
2018 Q3	-0.59 USD	-168.18%
2018 Q4	0.29 USD	149.15%
2018 FY	- USD	-157.14%
2018 Q1	-0.83 USD	-164.34%
2018 Q2	-0.22 USD	73.49%
2017 Q1	-0.81 USD	-42.11%
2017 Q2	-0.52 USD	35.8%
2017 Q3	-0.64 USD	-23.08%
2017 Q4	1.29 USD	301.56%
2017 FY	- USD	71.51%
2016 Q3	-0.62 USD	-67.57%
2016 Q2	-0.37 USD	-164.29%
2016 Q1	-0.14 USD	80.0%
2016 FY	- USD	-77.32%
2016 Q4	-0.57 USD	8.06%
2015 FY	- USD	-49.23%
2015 Q4	-0.70 USD	0.0%
2014 FY	- USD	0.0%

Peer Eps Comparison of Zymeworks Inc.

Name	Eps	Eps Difference
ADC Therapeutics SA	-2.94 USD	41.497%
Alto Neuroscience, Inc.	-1.35 USD	-27.407%
Annovis Bio, Inc.	-6.23 USD	72.392%
Biohaven Pharmaceutical Holding Company Ltd.	-5.73 USD	69.983%
Ginkgo Bioworks Holdings, Inc.	-18.37 USD	90.637%
Nuvation Bio Inc.	-0.35 USD	-391.429%
Nuvation Bio Inc.	-0.35 USD	-391.429%
Arcus Biosciences, Inc.	-4.15 USD	58.554%
Theriva Biologics, Inc.	-28.49 USD	93.963%